Cited 540 times in
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.